
Nationwide quality assurance of high-throughput diagnostic molecular testing during the SARS-CoV-2 pandemic : role of the Belgian National Reference Centre
- Author
- Reile Janssen, Lize Cuypers, Lies Laenen, Els Keyaerts, Kurt Beuselinck, Sunita Janssenswillen, Bram Slechten, Jannes Bode, Elke Wollants, Kristel Van Laethem, Annabel Rector, Mandy Bloemen, Anke Sijmons, Nathalie de Schaetzen, Arnaud Capron, Kurt Van Baelen, Thierry Pascal, Celine Vermeiren, Fabrice Bureau, Jo Vandesompele (UGent) , Pieter De Smet, Wouter Uten, Hugues Malonne, Pierre Kerkhofs, Jo De Cock, Veerle Matheeussen, Bruno Verhasselt (UGent) , Laurent Gillet, Gautier Detry, Bertrand Bearzatto, Jonathan Degosserie, Coralie Henin, Gregor Pairoux, Piet Maes, Marc Van Ranst, Katrien Lagrou, Elisabeth Dequeker, Emmanuel Andre and COVID-19 Genomics Belgium Consortium
- Organization
- Project
- Abstract
- Since the onset of the coronavirus disease (COVID-19) pandemic in Belgium, UZ/KU Leuven has played a crucial role as the National Reference Centre (NRC) for respiratory pathogens, to be the first Belgian laboratory to develop and implement laboratory developed diagnostic assays for SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) and later to assess the quality of commercial kits. To meet the growing demand for decentralised testing, both clinical laboratories and government-supported high-throughput platforms were gradually deployed across Belgium. Consequently, the role of the NRC transitioned from a specialised testing laboratory to strengthening capacity and coordinating quality assurance. Here, we outline the measures taken by the NRC, the national public health institute Sciensano and the executing clinical laboratories to ensure effective quality management of molecular testing throughout the initial two years of the pandemic (March 2020 to March 2022).
- Keywords
- National reference centre, High-throughput testing, Quality assurance, elgium, COVID-19, SARS-CoV-2
Downloads
-
12985 2024 Article 2308.pdf
- full text (Published version)
- |
- open access
- |
- |
- 1.85 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01HQ8GB8V5GJGY18P6EM4G7EC7
- MLA
- Janssen, Reile, et al. “Nationwide Quality Assurance of High-Throughput Diagnostic Molecular Testing during the SARS-CoV-2 Pandemic : Role of the Belgian National Reference Centre.” VIROLOGY JOURNAL, vol. 21, no. 1, 2024, doi:10.1186/s12985-024-02308-y.
- APA
- Janssen, R., Cuypers, L., Laenen, L., Keyaerts, E., Beuselinck, K., Janssenswillen, S., … Genomics Belgium Consortium, C.-19. (2024). Nationwide quality assurance of high-throughput diagnostic molecular testing during the SARS-CoV-2 pandemic : role of the Belgian National Reference Centre. VIROLOGY JOURNAL, 21(1). https://doi.org/10.1186/s12985-024-02308-y
- Chicago author-date
- Janssen, Reile, Lize Cuypers, Lies Laenen, Els Keyaerts, Kurt Beuselinck, Sunita Janssenswillen, Bram Slechten, et al. 2024. “Nationwide Quality Assurance of High-Throughput Diagnostic Molecular Testing during the SARS-CoV-2 Pandemic : Role of the Belgian National Reference Centre.” VIROLOGY JOURNAL 21 (1). https://doi.org/10.1186/s12985-024-02308-y.
- Chicago author-date (all authors)
- Janssen, Reile, Lize Cuypers, Lies Laenen, Els Keyaerts, Kurt Beuselinck, Sunita Janssenswillen, Bram Slechten, Jannes Bode, Elke Wollants, Kristel Van Laethem, Annabel Rector, Mandy Bloemen, Anke Sijmons, Nathalie de Schaetzen, Arnaud Capron, Kurt Van Baelen, Thierry Pascal, Celine Vermeiren, Fabrice Bureau, Jo Vandesompele, Pieter De Smet, Wouter Uten, Hugues Malonne, Pierre Kerkhofs, Jo De Cock, Veerle Matheeussen, Bruno Verhasselt, Laurent Gillet, Gautier Detry, Bertrand Bearzatto, Jonathan Degosserie, Coralie Henin, Gregor Pairoux, Piet Maes, Marc Van Ranst, Katrien Lagrou, Elisabeth Dequeker, Emmanuel Andre, and COVID-19 Genomics Belgium Consortium. 2024. “Nationwide Quality Assurance of High-Throughput Diagnostic Molecular Testing during the SARS-CoV-2 Pandemic : Role of the Belgian National Reference Centre.” VIROLOGY JOURNAL 21 (1). doi:10.1186/s12985-024-02308-y.
- Vancouver
- 1.Janssen R, Cuypers L, Laenen L, Keyaerts E, Beuselinck K, Janssenswillen S, et al. Nationwide quality assurance of high-throughput diagnostic molecular testing during the SARS-CoV-2 pandemic : role of the Belgian National Reference Centre. VIROLOGY JOURNAL. 2024;21(1).
- IEEE
- [1]R. Janssen et al., “Nationwide quality assurance of high-throughput diagnostic molecular testing during the SARS-CoV-2 pandemic : role of the Belgian National Reference Centre,” VIROLOGY JOURNAL, vol. 21, no. 1, 2024.
@article{01HQ8GB8V5GJGY18P6EM4G7EC7, abstract = {{Since the onset of the coronavirus disease (COVID-19) pandemic in Belgium, UZ/KU Leuven has played a crucial role as the National Reference Centre (NRC) for respiratory pathogens, to be the first Belgian laboratory to develop and implement laboratory developed diagnostic assays for SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) and later to assess the quality of commercial kits. To meet the growing demand for decentralised testing, both clinical laboratories and government-supported high-throughput platforms were gradually deployed across Belgium. Consequently, the role of the NRC transitioned from a specialised testing laboratory to strengthening capacity and coordinating quality assurance. Here, we outline the measures taken by the NRC, the national public health institute Sciensano and the executing clinical laboratories to ensure effective quality management of molecular testing throughout the initial two years of the pandemic (March 2020 to March 2022).}}, articleno = {{40}}, author = {{Janssen, Reile and Cuypers, Lize and Laenen, Lies and Keyaerts, Els and Beuselinck, Kurt and Janssenswillen, Sunita and Slechten, Bram and Bode, Jannes and Wollants, Elke and Van Laethem, Kristel and Rector, Annabel and Bloemen, Mandy and Sijmons, Anke and de Schaetzen, Nathalie and Capron, Arnaud and Van Baelen, Kurt and Pascal, Thierry and Vermeiren, Celine and Bureau, Fabrice and Vandesompele, Jo and De Smet, Pieter and Uten, Wouter and Malonne, Hugues and Kerkhofs, Pierre and De Cock, Jo and Matheeussen, Veerle and Verhasselt, Bruno and Gillet, Laurent and Detry, Gautier and Bearzatto, Bertrand and Degosserie, Jonathan and Henin, Coralie and Pairoux, Gregor and Maes, Piet and Van Ranst, Marc and Lagrou, Katrien and Dequeker, Elisabeth and Andre, Emmanuel and Genomics Belgium Consortium, COVID-19}}, issn = {{1743-422X}}, journal = {{VIROLOGY JOURNAL}}, keywords = {{National reference centre,High-throughput testing,Quality assurance,elgium,COVID-19,SARS-CoV-2}}, language = {{eng}}, number = {{1}}, pages = {{17}}, title = {{Nationwide quality assurance of high-throughput diagnostic molecular testing during the SARS-CoV-2 pandemic : role of the Belgian National Reference Centre}}, url = {{http://doi.org/10.1186/s12985-024-02308-y}}, volume = {{21}}, year = {{2024}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: